ALS is a progressive degeneration of motor neurons whose pathogenesis is unknown. Based on a leading hypothesis that the pathogenesis is autoimmune, this trial tests whether powerful immunosuppression with cyclophosphamide is effective in halting or significantly slowing the course of ALS.
Showing the most recent 10 out of 65 publications